Seer (SEER) Change in Accured Expenses (2020 - 2026)
Seer (SEER) recorded quarterly Change in Accured Expenses of -$2.4 million in Q1 2026, down 731.47% quarter-over-quarter from -$286000.0 in Q4 2025, and down 16.34% on a YoY basis from -$2.8 million in Q1 2025.
Seer (SEER) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Seer's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 16.34% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$854000.0 (up 46.56% YoY), while the FY2025 annual figure was -$520000.0, up 63.59% from the prior year.
- Change in Accured Expenses was -$2.4 million for Q1 2026 at Seer, down from -$286000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.4 million in Q2 2024 to a low of -$3.1 million in Q4 2024.
- Historically, Change in Accured Expenses has averaged -$172117.6 across 5 years, with a median of $161000.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 1922.81% in 2023, then sank 1081.47% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $615000.0 in 2022, then tumbled by 49.11% to $313000.0 in 2023, then tumbled by 1081.47% to -$3.1 million in 2024, then soared by 90.69% to -$286000.0 in 2025, then sank by 731.47% to -$2.4 million in 2026.
- The last three Change in Accured Expenses figures came in at -$2.4 million (Q1 2026), -$286000.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -286,000.00 |
| Dec 31, 2025 | -286,000.00 |
| Sep 30, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -3.07 Mn |
| Dec 31, 2024 | -3.07 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | 313,000.00 |
| Dec 31, 2023 | 313,000.00 |